Purchase Order 75D30122P13303
- Not listed
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, a non-profit organization and state-controlled institution of higher education. The $133,000 contract is for the development of monoclonal antibodies and immunoassays to spike variants, in support of the national response to the Coronavirus (COVID-19) pandemic. Georgia Tech Research Corporation has extensive...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $150,000 firm fixed price purchase order to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs, for bioinformatics technical services. The contract has a completion date of September 23, 2023 and does not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a...
- This is a $150,000 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs. The contract is for technical services and does not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a range of research,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $150,000.00 firm fixed price purchase order to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs, for bioinformatics services. This contract is not associated with a larger vehicle and did not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a wide range...
- This $150,000.00 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs. The contract is for bioinformatics technical services with a period of performance through September 2025. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the Georgia Institute of Technology. The...
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Institute of Technology Research Corporation (Georgia Tech Research Corp), doing business as the Office of Sponsored Programs. The contract, awarded on September 22, 2017, has a potential value of $301,682.00 and a completion date of March 31, 2019. The contract is not designated as a set-aside. Georgia Tech Research Corp is a non-profit...
- This is a $274,822.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs, on July 1, 2021. The contract supports FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 2 and has an ultimate completion date of April 29, 2022. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
- This federal contract award to Georgia Tech Research Corporation, valued at $121,467, is for the provision of services to enhance a daily source for the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The contract is a firm fixed-price purchase order with a completion date of December 31, 2016. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the Georgia Institute of Technology, which has...
- This $85,000.00 firm-fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (Georgia Tech), a non-profit research organization and state institution of higher education. The contract is for the development of a bioinformatics tool, and does not have a set-aside designation. Georgia Tech has a significant track record of securing federal contracts and grants across a wide range of technical domains, often...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation (Georgia Tech) for the development of anti-pertussis antibodies. The contract has a ceiling value of $112,500.00 and a period of performance through August 28, 2023. Georgia Tech is a non-profit research organization and state institution of higher education associated with the Georgia Institute of Technology. The contract does not have a set-aside...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract worth $133,000.00 to Georgia TECH Research Corporation, doing business as the Office of Sponsored Programs, for the development of monoclonal antibodies. This is a non-set-aside contract with a performance period ending on March 15, 2024. Georgia TECH Research Corporation, a non-profit research organization and state institution of higher education, has extensive experience executing federal prime and subcontracts for research, engineering, and technical services for agencies such as NASA, NSF, NIH, and DOD. This award represents the latest in a series of federal contract and grant activities focused on advancing scientific and technological capabilities across a wide range of disciplines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 4/14/23 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 9/27/22 | |
| Not listed | Not listed | $133.0k | 3/16/22 |